Introducing DiagnosysFST ProtocolsPosted on Wednesday June 2, 2021
Introducing DiagnosysFST® as a unique method to determine visual threshold of rod and cone performance using either Diagnosys ColorDome or ColorFlash stimulators.
With more than 15 years experience in clinical trials and over 45 peer-reviewed publications, DiagnosysFST® is now enhanced for clinical use. Normative data is soon to be released.
DiagnosysFST® continues to gain recognition as a necessary measurement of treatment efficacy in gene therapy trials for low vision patients.
We offer scotopic and photopic versions of all DiagnosysFST® protocols, each with a quality scoring metric to make interpretation simple.